| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 67,718 | 68,149 | 69,924 | 71,660 | | Cost of Revenue | 21,550 | 21,549 | 22,755 | 21,422 | | | Gross Profit | 46,168 | 46,600 | 47,169 | 50,238 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,413 | 1,538 | 1,976 | 2,018 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 19,828 | 21,412 | 22,391 | 24,578 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 24,927 | 23,650 | 22,802 | 23,642 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 134 | 1,556 | 179 | 443 | | Earnings Before Interest And Taxes | 25,061 | 25,206 | 22,981 | 24,085 | | Interest Expense | 875 | 881 | 930 | 981 | | Income Before Tax | 24,186 | 24,325 | 22,051 | 23,104 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| 10,153 | | | | Net Income From Continuing Ops | 24,186 | 24,325 | 22,051 | 33,257 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 24,186 | 24,325 | 22,051 | 33,257 | | Preferred Stock And Other Adjustments | 9,461 | (9,461) |
-
| 38,269 | | | Net Income Applicable To Common Shares | $33,647 | $14,864 | $22,051 | $71,526 |
|
0.11% Nasdaq 
0.01%
Income Statement
